CLASS II ONGOING Drug recall · Reported 10 Dec 2025 · FDA Enforcement Report
Lanashield Skin Barrier, Manfuactured recalled
Blossom Pharmaceuticals is recalling Lanashield Skin Barrier, Manfuactured for: Dynarex Corporation, 10 Gleshaw Street, distributed nationwide in the US. The recall was initiated on 31 Oct 2025 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0201-2026
- FDA event ID
- 97935
- Recalling firm
- Blossom Pharmaceuticals, Bardej, Goa
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- 31 Oct 2025
- FDA classified
- 2 Dec 2025
- Reported
- 10 Dec 2025
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Manufacturing (CGMP) Deviations
Timeline
| 31 Oct 2025 | Recall initiated by company | |
| 2 Dec 2025 | Classified by FDA | +32 days |
| 10 Dec 2025 | Published in enforcement report | +8 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
cGMP deviations
Product as listed by the FDA
Lanashield Skin Barrier, 4 oz. (113 g), Manfuactured for: Dynarex Corporation, 10 Gleshaw Street, Orangeburg, NY 10962 USA, Made in India, UPC 616784126319.
Where it was distributed
USA Nationwide
Questions about this recall
Why was it recalled?
cGMP deviations
Which lots are affected?
Lot #: A162301, Exp. Date 9/26; A162401, Exp. Date 4/27 & A162202, Exp. Date 11/25.
Where was it sold?
USA Nationwide
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other products in this recall event
12 other products · FDA event 97935This product is part of a recall event; the main page for the event is Globe Zinc Oxide Ointment USP Zinc Oxide 20% Skin Protectant recalled.
More recalls from Blossom Pharmaceuticals
All 13| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | WeCare, Zinc Oxide Ointment recalled by Blossom PharmaceuticalsZinc Oxide | Blossom Pharmaceuticals | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Dynagel, Moisturizing Wound Hydrogel recalled by Blossom Pharmaceuticals | Blossom Pharmaceuticals | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Globe Clotrimazole Cream USP, 1 % Antifungal Cream recalledClotrimazole | Blossom Pharmaceuticals | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Nivagen, Zinc Oxide Ointment recalled by Blossom PharmaceuticalsNivagen Zinc Oxide | Blossom Pharmaceuticals | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Globe Clotrimazole Cream, USP, 1 % recalled by Blossom PharmaceuticalsClotrimazole | Blossom Pharmaceuticals | Manufacturing (CGMP) Deviations | Nationwide |